
MALARIA VACCINE ADVANCEMENT: LONG-ACTING INJECTABLE SHOWS PROMISE IN CLINICAL TRIALS
Medicines for Malaria Venture (MMV) has announced a groundbreaking breakthrough in the fight against malaria with the development of a long-acting injectable (LAI) for malaria prevention. This innovative tool has demonstrated promising results in clinical trials, showing 90% efficacy in preventing malaria cases and protection lasting up to six months. According to MMV’s CEO, Dr….